T2 Biosystems (TTOO) News Today $0.41 +0.07 (+18.84%) (As of 12/26/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period StockNews.com Initiates Coverage on T2 Biosystems (NASDAQ:TTOO)December 20, 2024 | americanbankingnews.comT2 Biosystems announces sale of four T2Dx Intruments to European distributorDecember 18, 2024 | markets.businessinsider.comT2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European DistributorDecember 18, 2024 | finance.yahoo.comT2 Biosystems achieves milestone with 250,000th novel sepsis test shippedDecember 17, 2024 | markets.businessinsider.comT2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped GloballyDecember 17, 2024 | markets.businessinsider.comT2 Biosystems extends multi-year supplier agreement with VizientDecember 16, 2024 | markets.businessinsider.comT2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.December 16, 2024 | globenewswire.comT2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing PathogensDecember 9, 2024 | globenewswire.comT2 Biosystems Announces Third Quarter 2024 Financial ResultsNovember 15, 2024 | markets.businessinsider.comT2 Biosystems Reports Increased Losses and Cash CrunchNovember 15, 2024 | markets.businessinsider.comT2 Biosystems, Inc. (TTOO) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comT2 Biosystems to Report Third Quarter 2024 Financial Results and Business Updates on November 14, 2024November 5, 2024 | globenewswire.comT2 Biosystems Inc (TTOO) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic ...October 11, 2024 | finance.yahoo.comT2 Biosystems to Host Business Update Call on October 10, 2024October 8, 2024 | globenewswire.comT2 Biosystems To Sell Its FDA-Cleared Blood Diagnostics For Detection Of Sepsis-Causing PathogensOctober 7, 2024 | markets.businessinsider.comT2 Biosystems Announces Preliminary Third Quarter 2024 Financial ResultsOctober 7, 2024 | finance.yahoo.comT2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing PathogensOctober 7, 2024 | globenewswire.comT2 Biosystems (NASDAQ:TTOO) Stock, Short Interest ReportOctober 4, 2024 | benzinga.comT2 Biosystems Highlights New Article Published in The Lancet: Changing the Culture of Blood CultureSeptember 23, 2024 | finance.yahoo.comT2 Biosystems Defends Patent For Blood Pathogen Detection Method In EUSeptember 21, 2024 | markets.businessinsider.comT2 Biosystems Achieves Successful Defense of Patent for Direct-From-Whole Blood Pathogen Detection Method in the European UnionSeptember 20, 2024 | globenewswire.comT2 Biosystems Receives FDA Clearance to Market the T2Candida Panel for Pediatric PatientsSeptember 16, 2024 | markets.businessinsider.comT2 Biosystems Provides Updates on its New Product Development Pipeline ProgressSeptember 9, 2024 | finance.yahoo.comT2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Below 200-Day Moving Average of $4.27T2 Biosystems (NASDAQ:TTOO) Share Price Passes Below 200 Day Moving Average of $4.27September 7, 2024 | marketbeat.comT2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment ConferenceAugust 27, 2024 | globenewswire.comT2 Biosystems to Attend Upcoming Investor ConferencesAugust 1, 2024 | globenewswire.comT2 Biosystems, Inc. (NASDAQ:TTOO) Q2 2024 Earnings Call TranscriptJuly 30, 2024 | msn.comT2 Biosystems (NASDAQ:TTOO) Price Target Increased to $5.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group raised their price objective on shares of T2 Biosystems from $3.00 to $5.00 and gave the stock a "hold" rating in a research note on Tuesday.July 30, 2024 | marketbeat.comT2 Biosystems, Inc.: T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia DistributorJuly 30, 2024 | finanznachrichten.deT2 Biosystems Shares Rise as 2Q Loss per Share NarrowsJuly 29, 2024 | marketwatch.comT2 Biosystems, Inc. (TTOO) Q2 2024 Earnings Call TranscriptJuly 29, 2024 | seekingalpha.comTTOO Stock Earnings: T2 Biosystems Beats EPS, Misses Revenue for Q2 2024July 29, 2024 | markets.businessinsider.comT2 Biosystems Announces Second Quarter 2024 Financial ResultsJuly 29, 2024 | finance.yahoo.comT2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia DistributorJuly 29, 2024 | globenewswire.comT2 Biosystems Q2 2024 Earnings PreviewJuly 28, 2024 | msn.comT2 Biosystems to Report Second Quarter 2024 Financial Results and Business Updates on July 29, 2024July 22, 2024 | globenewswire.comT2 Biosystems files for $150M mixed securities shelfJuly 19, 2024 | msn.comT2 Biosystems (NASDAQ:TTOO) Stock Price Crosses Above Fifty Day Moving Average of $4.24T2 Biosystems (NASDAQ:TTOO) Share Price Crosses Above Fifty Day Moving Average of $4.24June 21, 2024 | marketbeat.comT2 Biosystems, Inc. (TTOO)May 25, 2024 | finance.yahoo.comT2 Biosystems regains compliance with Nasdaq rule on market value of listed securitiesMay 22, 2024 | msn.comT2 Biosystems Regains Compliance with Nasdaq Continued Listing RequirementsMay 22, 2024 | globenewswire.comT2 Biosystems Announces Closing of $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesMay 17, 2024 | globenewswire.comSector Update: Health Care Stocks Advance Late Wednesday AfternoonMay 15, 2024 | finance.yahoo.comT2 Biosystems Announces $8 Million Private Placement Priced At-The-Market Under Nasdaq RulesMay 15, 2024 | globenewswire.comT2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common StockMay 14, 2024 | finance.yahoo.comT2 Biosystems Announces CRG's Conversion from Preferred Stock to Common StockMay 14, 2024 | globenewswire.comT2 Biosystems: Hold Rating Maintained Amid Growth Prospects and Profitability ConcernsMay 7, 2024 | markets.businessinsider.comT2 Biosystems, Inc.: T2 Biosystems Announces First Quarter 2024 Financial ResultsMay 7, 2024 | finanznachrichten.deT2 Biosystems, Inc. (NASDAQ:TTOO) Q1 2024 Earnings Call TranscriptMay 7, 2024 | msn.comT2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseMay 7, 2024 | globenewswire.com Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol TTOO Media Mentions By Week TTOO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TTOO News Sentiment▼0.500.58▲Average Medical News Sentiment TTOO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TTOO Articles This Week▼11▲TTOO Articles Average Week Get T2 Biosystems News Delivered to You Automatically Sign up to receive the latest news and ratings for TTOO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IRIDEX News Today DarioHealth News Today Vivos Therapeutics News Today Femasys News Today BioSig Technologies News Today Co-Diagnostics News Today Allurion Technologies News Today NeurAxis News Today PolyPid News Today Microbot Medical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TTOO) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T2 Biosystems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share T2 Biosystems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.